We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Companion Diagnostics Guidance Needs Clarity, Industry Says
FDA Companion Diagnostics Guidance Needs Clarity, Industry Says
The FDA’s draft guidance on companion diagnostics development needs more clarity on what products it covers and greater detail on clinical trial criteria, trade groups said in comments.